Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study investigates potential protective effect of atorvastatin pre-treatment in patient
with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) on
chronic statin therapy. Patients are randomized into two groups: atorvastatin pre-treatment
group (80mg atorvastatin seven days before PCI) and control group (PCI without atorvastatin
pretreatment, chronic statin treatment). Endpoint is myocardial infarction measured by
troponin I and creatine kinase myocardial band.